Chenfeng Wang
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- RNA Research and Splicing
- Ubiquitin and proteasome pathways
- Circular RNAs in diseases
Papers in
-
- RNA modifications and cancer 6
- Epigenetics and DNA Methylation 3
- RNA Research and Splicing 3
- Renal and related cancers 2
-
- Cancer-related molecular mechanisms research 3
- MicroRNA in disease regulation 2
- Co-authors
- Yide Mei (5 shared papers)Yang Yang (3 shared papers)Decai Wang (3 shared papers)Kailiang Zhao (3 shared papers)Guang Zhang (2 shared papers)Xianning Wu (2 shared papers)Yang Yang (1 shared paper)Ge Shan (1 shared paper)
- Journals
- Cell Death and Disease (3 papers)EMBO Reports (2 papers)International Journal of Medical Sciences (1 paper)Frontiers in Immunology (1 paper)International Journal of Biological Sciences (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Chenfeng Wang
23 papers receiving 384 citations
Peers
Comparison fields: 5 of 71
- Cancer Research 144
- Molecular Biology 259
- Oncology 70
- Neurology 17
- Immunology 41
Countries citing papers authored by Chenfeng Wang
This map shows the geographic impact of Chenfeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenfeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenfeng Wang more than expected).
Fields of papers citing papers by Chenfeng Wang
This network shows the impact of papers produced by Chenfeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenfeng Wang. The network helps show where Chenfeng Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Chenfeng Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 64 | |
| 2 | 2018 | 57 | |
| 3 | 2021 | 38 | |
| 4 | 2023 | 35 | |
| 5 | 2018 | 33 | |
| 6 | 2021 | 25 | |
| 7 | 2025 | 17 | |
| 8 | 2020 | 17 | |
| 9 | 2022 | 15 | |
| 10 | 2022 | 15 | |
| 11 | 2021 | 14 | |
| 12 | 2022 | 12 | |
| 13 | 2020 | 12 | |
| 14 | 2021 | 7 | |
| 15 | Polymorphisms in UGT2B4 and susceptibility to pancreatic cancer. | 2015 | 7 |
| 16 | 2020 | 7 | |
| 17 | 2021 | 4 | |
| 18 | 2022 | 3 | |
| 19 | 2024 | 1 | |
| 20 | 2024 | 1 |
About Chenfeng Wang
Chenfeng Wang is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Surgery, having authored 25 papers that have together received 387 indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), Epigenetics and DNA Methylation (3 papers), RNA Research and Splicing (3 papers), Cancer-related molecular mechanisms research (3 papers), Renal cell carcinoma treatment (3 papers), MicroRNA in disease regulation (2 papers), Renal and related cancers (2 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Cancer Research (144 citations), Molecular Biology (259 citations), Oncology (70 citations), Neurology (17 citations) and Immunology (41 citations). Chenfeng Wang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Yide Mei, Yang Yang, Decai Wang, Kailiang Zhao, Guang Zhang, Xianning Wu, Yang Yang, Ge Shan, Mian Wu and Xiaoling Ma. Their work appears in journals such as Cell Death and Disease, EMBO Reports, International Journal of Medical Sciences, Frontiers in Immunology and International Journal of Biological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.